BBA
PTLA

Baker Bros. Advisors’s Portola Pharmaceuticals, Inc. PTLA Stock Holding History

Baker Bros. Advisors’s Portfolio PTLA Stock Details PTLA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q2 		– Sell
-182,591
Closed -$4.73M – 111
2014
Q1 		$4.73M Sell
182,591
-41,843
-19% -$1.12M 0.06% 75
2013
Q4 		$5.78M Sell
224,434
-75,477
-25% -$1.83M 0.08% 61
2013
Q3 		$8.02M Sell
299,911
-100,003
-25% -$2.38M 0.11% 48
2013
Q2 		$9.83M Buy
+399,914
New +$7.95M 0.19% 36

Other funds holding PTLA

Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Temasek Holdings
Temasek Holdings Singapore $30.5B AUM 13.98% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
EAM
Eagle Asset Management St Petersburg, Florida $19.6B AUM 41.58% 1-Year Est. Return
SAM
Sectoral Asset Management Montreal, Quebec, Canada $121M AUM 73.47% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

Baker Bros. Advisors's PTLA Position: Q2 2014 in Review

Baker Bros. Advisors sold out of Portola Pharmaceuticals, Inc. (PTLA) in Q2 2014, closing a stake of 182,591 shares — an estimated $4.73M sold.

Baker Bros. Advisors first reported a position in PTLA in Q2 2013 and held it in 4 quarters. The position peaked at $9.83M in Q2 2013. 110 funds tracked by Wall St. Rank hold PTLA as of Q2 2014.

  • Baker Bros. Advisors reported no remaining Portola Pharmaceuticals, Inc. position as of Q2 2014 after selling out during the quarter.
  • Baker Bros. Advisors sold 182,591 Portola Pharmaceuticals, Inc. shares in Q2 2014, an estimated $4.73M.
  • Baker Bros. Advisors first reported a position in Portola Pharmaceuticals, Inc. in Q2 2013 and held it in 4 quarters.
  • Baker Bros. Advisors's Portola Pharmaceuticals, Inc. position peaked at $9.83M in Q2 2013.
  • 110 funds tracked by Wall St. Rank held Portola Pharmaceuticals, Inc. as of Q2 2014.

Based on Baker Bros. Advisors's 13F filing for Q2 2014, filed 14 Aug 2014.